Literature DB >> 23619755

NUB1 snubs huntingtin toxicity.

Rebecca Aron1, Andrey Tsvetkov, Steven Finkbeiner.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23619755     DOI： 10.1038/nn.3380

Source DB:  PubMed          Journal:  Nat Neurosci        ISSN： 1097-6256            Impact factor:   24.884


× No keyword cloud information.
  15 in total

1.  Reversal of neuropathology and motor dysfunction in a conditional model of Huntington's disease.

Authors:  A Yamamoto; J J Lucas; R Hen
Journal:  Cell       Date:  2000-03-31       Impact factor: 41.582

2.  Immunoproteasomes preserve protein homeostasis upon interferon-induced oxidative stress.

Authors:  Ulrike Seifert; Lukasz P Bialy; Frédéric Ebstein; Dawadschargal Bech-Otschir; Antje Voigt; Friederike Schröter; Timour Prozorovski; Nicole Lange; Janos Steffen; Melanie Rieger; Ulrike Kuckelkorn; Orhan Aktas; Peter-M Kloetzel; Elke Krüger
Journal:  Cell       Date:  2010-08-20       Impact factor: 41.582

3.  Sustained therapeutic reversal of Huntington's disease by transient repression of huntingtin synthesis.

Authors:  Holly B Kordasiewicz; Lisa M Stanek; Edward V Wancewicz; Curt Mazur; Melissa M McAlonis; Kimberly A Pytel; Jonathan W Artates; Andreas Weiss; Seng H Cheng; Lamya S Shihabuddin; Gene Hung; C Frank Bennett; Don W Cleveland
Journal:  Neuron       Date:  2012-06-21       Impact factor: 17.173

4.  NUB1 suppresses the formation of Lewy body-like inclusions by proteasomal degradation of synphilin-1.

Authors:  Kunikazu Tanji; Tomoaki Tanaka; Fumiaki Mori; Katsumi Kito; Hitoshi Takahashi; Koichi Wakabayashi; Tetsu Kamitani
Journal:  Am J Pathol       Date:  2006-08       Impact factor: 4.307

5.  Single-step detection of mutant huntingtin in animal and human tissues: a bioassay for Huntington's disease.

Authors:  Andreas Weiss; Dorothée Abramowski; Miriam Bibel; Ruth Bodner; Vanita Chopra; Marian DiFiglia; Jonathan Fox; Kimberly Kegel; Corinna Klein; Stephan Grueninger; Steven Hersch; David Housman; Etienne Régulier; H Diana Rosas; Muriel Stefani; Scott Zeitlin; Graeme Bilbe; Paolo Paganetti
Journal:  Anal Biochem       Date:  2009-08-06       Impact factor: 3.365

6.  Protein turnover and inclusion body formation.

Authors:  Siddhartha Mitra; Andrey S Tsvetkov; Steven Finkbeiner
Journal:  Autophagy       Date:  2009-10       Impact factor: 16.016

7.  Identification of NUB1 as a suppressor of mutant Huntington toxicity via enhanced protein clearance.

Authors:  Boxun Lu; Ismael Al-Ramahi; Antonio Valencia; Qiong Wang; Frada Berenshteyn; Haidi Yang; Tatiana Gallego-Flores; Salah Ichcho; Arnaud Lacoste; Marc Hild; Marian Difiglia; Juan Botas; James Palacino
Journal:  Nat Neurosci       Date:  2013-03-24       Impact factor: 24.884

8.  Huntingtin interacting proteins are genetic modifiers of neurodegeneration.

Authors:  Linda S Kaltenbach; Eliana Romero; Robert R Becklin; Rakesh Chettier; Russell Bell; Amit Phansalkar; Andrew Strand; Cameron Torcassi; Justin Savage; Anthony Hurlburt; Guang-Ho Cha; Lubna Ukani; Cindy Lou Chepanoske; Yuejun Zhen; Sudhir Sahasrabudhe; James Olson; Cornelia Kurschner; Lisa M Ellerby; John M Peltier; Juan Botas; Robert E Hughes
Journal:  PLoS Genet       Date:  2007-05-11       Impact factor: 5.917

9.  NUB1 promotes cytoplasmic localization of p53 through cooperation of the NEDD8 and ubiquitin pathways.

Authors:  G Liu; D P Xirodimas
Journal:  Oncogene       Date:  2010-01-25       Impact factor: 9.867

10.  Cannabinoid receptor 2 signaling in peripheral immune cells modulates disease onset and severity in mouse models of Huntington's disease.

Authors:  Jill Bouchard; Jennifer Truong; Kristofer Bouchard; Diana Dunkelberger; Sandrine Desrayaud; Saliha Moussaoui; Sarah J Tabrizi; Nephi Stella; Paul J Muchowski
Journal:  J Neurosci       Date:  2012-12-12       Impact factor: 6.167
View more
  1 in total

Review 1.  Targeting the proteostasis network in Huntington's disease.

Authors:  Tânia R Soares; Sara D Reis; Brígida R Pinho; Michael R Duchen; Jorge M A Oliveira
Journal:  Ageing Res Rev       Date:  2018-11-28       Impact factor: 10.895
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.